Fosagen 70 mg. Tablets
PDF Leaflet Revision Date: 06 February 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of postmenopausal osteoporosis to reduce fracture risk.
Dosage (summary)
One tablet (70 mg) once weekly, taken with water, at least 2 hours before/after food or other medications.
Special Populations
- Elderly
- Renal impairment (creatinine clearance < 35 ml/min)
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Food and beverages (including mineral water)
- Calcium supplements
- Antacids
Contraindications
- Hypersensitivity to alendronate
- Severe renal impairment
- Gastrointestinal problems
- Inability to remain upright for 30 mins
Common side effects
- Abdominal pain
- Dyspepsia
- Oesophageal irritation
- Musculoskeletal pain
Counselling Points
- Take with a full glass of water
- Remain upright for 30 minutes after taking
- Do not take at bedtime or before arising
Serious warnings
- Osteonecrosis of the jaw
- Hypocalcaemia
- Upper gastrointestinal adverse reactions
Important Disclaimer
The Fosagen 70 mg. Tablets professional information leaflet below is the property of Viatris Healthcare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
